| Execution period | 36 months (director re-appointment term) |
|---|
BSE filing, NSE: ARCIL. Summary written from the filing by ALFA Finder's alert engine.
Asset Reconstruction Company (India) Ltd: key numbers
- Share price
- ₹123.39
- Market cap
- ₹4,009 Cr
- Revenue (annual)
- ₹753.0 Cr
- Net profit (annual)
- ₹407.8 Cr
- Promoter holding
- 77.45%
- FII holding
- 6.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asset Reconstruction Company (India) Ltd
All →Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Asset Reconstruction Company (India) Q2 FY27 Results: Net Profit ₹157.8 Cr, Up 55.8% YoY
Asset Reconstruction Company (India) Ltd reported revenue from operations of ₹276.5 Cr (+30.7% YoY) and net profit of ₹157.8 Cr (+55.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.8 Cr · +55.8% YoY
Asset Reconstruction Company (India) Board Meeting Date
ARCIL will hold a board meeting on 29 October 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window is closed from 1 October to 1 November 2026.
Asset Reconstruction Company (India) Other Announcement
Asset Reconstruction Company (India) Ltd filed its quarterly shareholding pattern as mandated under SEBI regulations. This routine disclosure details the company's current shareholder structure.
Asset Reconstruction Company (India) Earnings Call Transcript: Key Takeaways
ARCIL reported a 107% PAT jump in Q1 FY27, driven by chunky corporate resolutions despite seasonal lulls in asset acquisitions. Management is pivoting towards retail and MSME segments while leveraging technology for collections.
Asset Reconstruction Company (India) Results Update
ARCIL reported Q1 FY27 results with PAT doubling to Rs. 143.1 crore on 151% YoY recovery growth. Total income rose 115% to Rs. 276.1 crore, driven by corporate and retail collections.
Other management change announcements
All →Ambani Orgochem Management Change
Ambani Orgochem announced the resignation of non-executive non-independent director Bhavin Patel, effective 29 October 2026. The resignation was attributed to professional priorities and commitments.
3i Infotech Management Change
3i Infotech appointed Shirsendu Chaudhuri as Chief Growth Officer, a senior management role, effective October 29, 2026. He brings over 22 years of experience in IT services, enterprise software and SaaS.
Travel Food Services Management Change
Travel Food Services appointed Avinash Yogeshwar as Senior Managerial Personnel, effective 29 October 2026. It is a senior leadership change with no financial impact.
Swan Defence and Heavy Industries Management Change
Swan Defence designated three existing employees as Senior Management Personnel effective 29 October 2026, following organisational restructuring. The move reflects leadership reorganisation, not new capital or contracts.
Prima Innovation Management Change
Prima Innovation Limited reported the resignation of Non-Executive Director Dilip M. Parekh, effective 29-10-2026, citing personal reasons. The exit is a board-level change investors should note.
Strides Pharma Science Management Change
Strides Pharma's board appointed Biren Gabhawala as Non-Executive Independent Director effective November 1, 2026, for five years. He is a Chartered Accountant with extensive audit and listed-company board experience.
- Execution
- Five-year term effective November 1, 2026